288 related articles for article (PubMed ID: 34782464)
1. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases.
Choi JK; Yu CR; Bing SJ; Jittayasothorn Y; Mattapallil MJ; Kang M; Park SB; Lee HS; Dong L; Shi G; Caspi RR; Egwuagu CE
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782464
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis.
Kang M; Choi JK; Jittayasothorn Y; Egwuagu CE
Front Immunol; 2020; 11():1051. PubMed ID: 32547555
[TBL] [Abstract][Full Text] [Related]
3. IL-27-containing exosomes secreted by innate B-1a cells suppress and ameliorate uveitis.
Kang M; Yadav MK; Mbanefo EC; Yu CR; Egwuagu CE
Front Immunol; 2023; 14():1071162. PubMed ID: 37334383
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Regulatory B Cells in Experimental Autoimmune Uveitis.
Choi JK; Egwuagu CE
Methods Mol Biol; 2021; 2270():437-450. PubMed ID: 33479912
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.
Egwuagu CE; Yu CR
Crit Rev Immunol; 2015; 35(1):49-57. PubMed ID: 25746047
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 35 Regulatory B Cells.
Choi JK; Egwuagu CE
J Mol Biol; 2021 Jan; 433(1):166607. PubMed ID: 32755620
[TBL] [Abstract][Full Text] [Related]
7. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements.
Yu CR; Choi JK; Uche AN; Egwuagu CE
J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 induces regulatory B cells that suppress autoimmune disease.
Wang RX; Yu CR; Dambuza IM; Mahdi RM; Dolinska MB; Sergeev YV; Wingfield PT; Kim SH; Egwuagu CE
Nat Med; 2014 Jun; 20(6):633-41. PubMed ID: 24743305
[TBL] [Abstract][Full Text] [Related]
9. Deletion of
Kang M; Lee HS; Choi JK; Yu CR; Egwuagu CE
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803441
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.
Egwuagu CE; Yu CR; Sun L; Wang R
Cytokine Growth Factor Rev; 2015 Oct; 26(5):587-93. PubMed ID: 26279360
[TBL] [Abstract][Full Text] [Related]
11. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.
Dambuza IM; He C; Choi JK; Yu CR; Wang R; Mattapallil MJ; Wingfield PT; Caspi RR; Egwuagu CE
Nat Commun; 2017 Sep; 8(1):719. PubMed ID: 28959012
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of gut-originating regulatory B cells in neuroinflammatory diseases.
Neziraj T; Siewert L; Pössnecker E; Pröbstel AK
Eur J Immunol; 2023 Nov; 53(11):e2250033. PubMed ID: 37624875
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA sequencing analysis reveals the heterogeneity of IL-10 producing regulatory B cells in lupus-prone mice.
Daamen AR; Alajoleen RM; Grammer AC; Luo XM; Lipsky PE
Front Immunol; 2023; 14():1282770. PubMed ID: 38155972
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing CD19-independent GL7(-) Breg cells are expanded during inflammation and in mice with lupus-like disease.
Wang X; Wei Y; Xiao H; Liu X; Zhang Y; Han G; Chen G; Hou C; Zhang L; Ma N; Shen B; Li Y; Egwuagu CE; Wang R
Mol Immunol; 2016 Mar; 71():54-63. PubMed ID: 26852110
[TBL] [Abstract][Full Text] [Related]
16. STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
Oladipupo FO; Yu CR; Olumuyide E; Jittaysothorn Y; Choi JK; Egwuagu CE
Sci Rep; 2020 Oct; 10(1):16188. PubMed ID: 33004854
[TBL] [Abstract][Full Text] [Related]
17. APRIL Induces a Novel Subset of IgA
Fehres CM; van Uden NO; Yeremenko NG; Fernandez L; Franco Salinas G; van Duivenvoorde LM; Huard B; Morel J; Spits H; Hahne M; Baeten DLP
Front Immunol; 2019; 10():1368. PubMed ID: 31258536
[TBL] [Abstract][Full Text] [Related]
18. Suppressive mechanisms of regulatory B cells in mice and humans.
Matsumura Y; Watanabe R; Fujimoto M
Int Immunol; 2023 Feb; 35(2):55-65. PubMed ID: 36153768
[TBL] [Abstract][Full Text] [Related]
19. TLR9 mediated regulatory B10 cell amplification following sub-total body irradiation: Implications in attenuating EAE.
Hong J; Fang J; Lan R; Tan Q; Tian Y; Zhang M; Okunieff P; Zhang L; Lin J; Han D
Mol Immunol; 2017 Mar; 83():52-61. PubMed ID: 28110075
[TBL] [Abstract][Full Text] [Related]
20. The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5.
Radomir L; Kramer MP; Perpinial M; Schottlender N; Rabani S; David K; Wiener A; Lewinsky H; Becker-Herman S; Aharoni R; Milo R; Mauri C; Shachar I
Nat Commun; 2021 Mar; 12(1):1893. PubMed ID: 33767202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
